In a world where innovative therapies are entering the market at an unprecedented pace, stakeholders need quick access to reliable information to help ensure the health care system is working as it should. They need fresh perspectives and data to keep up with how tools and techniques are working to help maintain balance in the managed care ecosystem. Enter AMCP’s recently released 2024 Access, Affordability, and Outcomes (AAO) report, which serves as a useful guide on how managed care pharmacy tools drive impact for patients.
Measures of medication adherence to noninsulin diabetes medications (NIDM), statins, and renin angiotensin system antagonists (RASA) have been continuously used in the star ratings program since 2012. Adherence to these treatments is undoubtedly important. However, the consistent use of these measures in the star ratings program over time has limitations.
AMCP webinar that detailed the state of the performance measurement landscape, profiles how quality impacts team-based models of care, the Enhanced MTM program, and others, and describes why this impact matters in managed care.
AMCP webinar that detailed the state of the performance measurement landscape, profiles how quality impacts team-based models of care, the Enhanced MTM program, and others, and describes why this impact matters in managed care.
AMCP CEO Blog: People can accomplish remarkable things when they work toward a common goal. That’s what happened recently when a diverse group of pharmacy stakeholders gathered to develop standardized terms for MTM services.